On Friday, Owens & Minor Inc. (NYSE:OMI) reported that the second quarter of 2024 adjusted EPS of $0.36, double the $0.18 reported a year ago, beating the consensus of $0.33. The company reported sales of $2.671 billion, up 4% year-over-year, almost in line with the consensus of $2.646 billion. Patient Direct revenue of $660 million, up 4% compared to the second quarter of 2023, driven by continued strong growth in diabetes and sleep supplies. Related: Healthcare Logistics Service Firm Owens & Minor To Buy Home-Based Care Equipment Firm For $1.4B, Sees ...